| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000011592 |
| Receipt No. | R000013553 |
| Official scientific title of the study | The impact of continuous positive airway pressure (CPAP) on aortic aneurysms in patients with obstructive sleep apnea |
| Date of disclosure of the study information | 2014/01/01 |
| Last modified on | 2016/08/29 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | The impact of continuous positive airway pressure (CPAP) on aortic aneurysms in patients with obstructive sleep apnea | |
| Title of the study (Brief title) | The impact of CPAP on aortic aneurysms in patients with OSA | |
| Region |
|
|
| Condition | |||
| Condition | obstructive sleep apnea
aortic aneurysm |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study is aimed at investigating whether CPAP therapy can attenuate aortic aneurysm expansion in patients with obstructive sleep apnea, in order to explore the causal relationship between aortic aneurysm expansion and obstructive sleep apnea. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The changes in the expansion rate of aortic aneurysms (mm/year) before and after the CPAP treatment |
| Key secondary outcomes | 1. Expansion rate (mm/year) of aortic aneurysms in patients without CPAP treatment
2. Prevalence of OSA in patients with aortic aneurysm 3. Events associated with aortic aneurysm 4. Cardiovascular events 5. Changes in biomarkers of aortic aneurysm 6. Changes in blood pressure and endothelial function 7. Changes in epicardial fat and visceral fat volume 8. Changes in sleep duration |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients with apnea-hypopnea index (AHI)>20
CPAP treatment (during sleep, everyday) |
|
| Interventions/Control_2 | Patients with apnea-hypopnea index (AHI)<20
No treatment |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with thoracic aortic aneurysm (TAA) or abdominal aortic aneurysm (AAA)
2. Diameter of aortic aneurysm has been measured by CT for at least one year 3. Receiving appropriate treatments for hypertension, dyslipidemia, and/or diabetes |
|||
| Key exclusion criteria | 1. Previous or current treatments for sleep apnea.
2. Previous treatment for aortic aneurysm 3. Planned intervention for aortic aneurysm 4. Central sleep apnea syndrome 5. Long-term oxygen therapy 6. Aortic aneurysm associated with hereditary diseases (e.g. Marfan syndrome) 7. Unable to use CPAP 8. Hope for treatments other than CPAP for OSA 9. Surgery of upper airway within 90 days |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuo Chin |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Respiratory Care and Sleep Control Medicine |
| Address | Shogoin 54, Kawahara-cho, Sakyo-Ku, Kyoto, Japan |
| TEL | 81-(0)75-751-3852 |
| chink@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Kazuo Chin |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Respiratory Care and Sleep Control Medicine |
| Address | Shogoin 54, Kawahara-cho, Sakyo-Ku, Kyoto, Japan |
| TEL | 81-(0)75-751-3852 |
| Homepage URL | http://kukonai.com/office/class/ |
| ryotkw@gmail.com | |
| Sponsor | |
| Institute | Graduate School of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013553 |